Sign Up Today and Learn More About Somatus Stock
Invest in or calculate the value of your shares in Somatus or other pre-IPO companies through EquityZen's platform.
Somatus Stock (SOMA)
Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.
About Somatus Stock
Founded
2016
Headquarters
Mclean, VA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Somatus is a healthcare company that partners with health plans, health systems, and nephrology, and primary care groups. It provides integrated care for patients with or at risk of developing kidney disease. Somatus' vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia and is founded by a team of healthcare operators, entrepreneurs, and clinicians who treat kidney disease.
Somatus Press Mentions
Stay in the know about the latest news on Somatus
Somatus Achieves 4-Star Rating for Health Plan Partner Kidney Population Through Whole-Person Clinical Quality ...
prnewswire • Jun 26, 2024
Sun Life partners with Somatus to provide comprehensive services for late-stage kidney disease and cardiovascular care
prnewswire • Apr 06, 2024
Sun Life US partners with Somatus
coverager • Feb 18, 2024
Greater Good Health Raises $20M in Series A Funding
finsmes • Jan 25, 2024
New Standards of Care
thebossmagazine • Dec 19, 2023
Investors in Somatus
Discover investors in Somatus stock and explore their portfolio companies
Somatus Management
Leadership team at Somatus
Co-Founder and Chief Executive Officer
Ikenna Okezie
Chief Financial Officer
Jon Kunkle
Join now and verify your accreditation status to gain access to:
- Somatus current valuation
- Somatus stock price
- Available deals in Somatus and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Somatus Stock
How to invest in Somatus stock?
Accredited investors can buy pre-IPO stock in companies like Somatus through EquityZen funds. These investments are made available by existing Somatus shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Somatus stock?
Shareholders can sell their Somatus stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
